ADMA Biologics, Inc. (ADMA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

ADMA Biologics, Inc. (ADMA) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

ADMA Income Statement

ADMA Biologics, Inc. (ADMA) annual income statement — 19-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	124.39M	114.49M	139.16M	134.22M	121.98M	114.8M	117.55M	119.84M	107.19M	81.88M	73.9M	67.28M	60.12M	56.91M	49.98M	41.09M	33.91M	29.1M	26.38M	20.68M
Revenue Growth %	1.98%	-0.27%	18.39%	12%	13.8%	40.22%	59.06%	78.13%	78.29%	43.86%	47.86%	63.73%	77.33%	95.56%	89.45%	98.69%	90.15%	81.34%	89.04%	101.24%
Cost of Goods Sold	38.12M	33.74M	50.35M	58.6M	54.76M	53.7M	54.22M	60.18M	49.74M	42.77M	42.82M	42.62M	43.43M	40.4M	35.8M	31.43M	26.14M	25.44M	22.87M	20.3M
COGS % of Revenue	30.64%	29.47%	36.18%	43.66%	44.89%	46.78%	46.12%	50.22%	46.4%	52.23%	57.94%	63.35%	72.24%	70.99%	71.64%	76.5%	77.08%	87.42%	86.69%	98.14%
Gross Profit	86.28M	80.75M	88.82M	75.63M	67.23M	61.1M	63.33M	59.66M	57.45M	39.11M	31.09M	24.65M	16.69M	16.51M	14.18M	9.66M	7.77M	3.66M	3.51M	385.34K
Gross Margin %	69.36%	70.53%	63.82%	56.34%	55.11%	53.22%	53.88%	49.78%	53.6%	47.77%	42.06%	36.65%	27.76%	29.01%	28.36%	23.5%	22.92%	12.58%	13.31%	1.86%
Gross Profit Growth %	28.34%	32.17%	40.24%	26.76%	17.01%	56.23%	103.73%	141.99%	244.24%	136.83%	119.27%	155.3%	114.82%	350.92%	303.73%	2406.02%	875.36%	312.72%	168.12%	124.4%
Operating Expenses	33.83M	30.4M	26.07M	24.61M	24.43M	26.22M	25.01M	20.02M	18.25M	17.29M	16.85M	15.97M	17.16M	17.33M	20.24M	18.97M	16.94M	18.48M	16.7M	14.82M
OpEx % of Revenue	27.2%	26.55%	18.73%	18.34%	20.03%	22.84%	21.28%	16.71%	17.03%	21.11%	22.8%	23.74%	28.55%	30.44%	40.49%	46.17%	49.98%	63.49%	63.31%	71.67%
Selling, General & Admin	26.74M	26.74M	23.51M	23.05M	22.21M	24.08M	23.32M	18.56M	16.61M	15.64M	15.53M	14.73M	14.25M	14.51M	13.89M	12.89M	11.97M	13.7M	11.7M	10.73M
SG&A % of Revenue	21.49%	23.36%	16.9%	17.17%	18.21%	20.97%	19.84%	15.49%	15.49%	19.1%	21.02%	21.89%	23.7%	25.5%	27.8%	31.38%	35.31%	47.07%	44.34%	51.87%
Research & Development	6.01M	2.6M	1.38M	1.53M	1.03M	826K	391K	412K	560K	450K	445.49K	596K	1.4M	855K	1.07M	1.04M	873.39K	624.11K	728.99K	770.56K
R&D % of Revenue	4.83%	2.27%	0.99%	1.14%	0.85%	0.72%	0.33%	0.34%	0.52%	0.55%	0.6%	0.89%	2.33%	1.5%	2.15%	2.54%	2.58%	2.14%	2.76%	3.73%
Other Operating Expenses	1000K	1000K	1000K	38K	1000K	1000K	1000K	1000K	1000K	1000K	872.7K	646K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Operating Income	52.45M	50.29M	62.75M	51.01M	42.8M	34.88M	38.32M	39.64M	39.2M	21.82M	14.23M	8.69M	-473K	-813K	-6.06M	-9.32M	-9.17M	-14.82M	-13.19M	-14.44M
Operating Margin %	42.16%	43.93%	45.09%	38.01%	35.08%	30.38%	32.6%	33.08%	36.57%	26.65%	19.26%	12.91%	-0.79%	-1.43%	-12.12%	-22.67%	-27.06%	-50.91%	-50%	-69.81%
Operating Income Growth %	22.54%	44.19%	63.74%	28.69%	9.18%	59.85%	169.25%	356.4%	8387.74%	2784.01%	334.93%	193.22%	94.84%	94.51%	54.07%	35.47%	41.12%	2.3%	23.4%	-4.61%
EBITDA	56.06M	52.13M	64.8M	53.03M	44.86M	36.85M	40.27M	41.58M	41.25M	23.93M	16.34M	10.78M	1.63M	1.22M	-4.12M	-7.45M	-7.45M	-13.22M	-11.67M	-13.01M
EBITDA Margin %	45.07%	45.53%	46.56%	39.51%	36.77%	32.1%	34.26%	34.69%	38.48%	29.23%	22.11%	16.02%	2.7%	2.14%	-8.25%	-18.14%	-21.97%	-45.44%	-44.25%	-62.93%
EBITDA Growth %	24.99%	41.47%	60.92%	27.56%	8.75%	53.96%	146.4%	285.8%	2438.34%	1861.89%	496.49%	244.57%	121.81%	109.23%	64.69%	42.72%	47.74%	5.09%	26.99%	-1.95%
D&A (Non-Cash Add-back)	3.62M	1.84M	2.05M	2.02M	2.06M	1.97M	1.94M	1.94M	2.05M	2.11M	2.11M	2.09M	2.1M	2.03M	1.94M	1.86M	1.72M	1.59M	1.52M	1.42M
EBIT	53.66M	59.23M	63.22M	49.19M	41.93M	35.42M	37.59M	40.25M	39.63M	22.17M	-11.43M	8.96M	-72K	-674K	-6.49M	-9.32M	-9.19M	-21.62M	-13.33M	-14.41M
Net Interest Income	-2.19M	-1.01M	-1.14M	-1.3M	-1.43M	-1.37M	-2.28M	-2.83M	-3.33M	-3.38M	-5.6M	-5.97M	-5.88M	-5.95M	-5.73M	-5.57M	-4.57M	-3.36M	-3.31M	-3.29M
Interest Income	1.24M	1.09M	487K	376K	400K	608K	598K	666K	449K	384K	612.45K	423.28K	414.3K	166.97K	2.26K	7.24K	2.27K	33.07K	2.29K	4.26K
Interest Expense	3.42M	2.1M	1.63M	1.68M	1.83M	1.98M	2.88M	3.5M	3.78M	3.77M	6.21M	6.4M	6.3M	6.12M	5.74M	5.58M	4.57M	3.39M	3.32M	3.3M
Other Income/Expense	-2.21M	6.83M	-1.16M	-3.5M	-2.7M	-1.43M	-3.61M	-2.89M	-3.35M	-3.42M	-31.88M	-6.12M	-5.9M	-5.98M	-6.17M	-5.58M	-4.59M	-10.19M	-3.46M	-3.28M
Pretax Income	50.24M	57.13M	61.59M	47.52M	40.1M	33.45M	34.71M	36.75M	35.85M	18.4M	-17.64M	2.56M	-6.37M	-6.79M	-12.23M	-14.9M	-13.76M	-25.01M	-16.65M	-17.71M
Pretax Margin %	40.39%	49.9%	44.26%	35.4%	32.87%	29.14%	29.53%	30.67%	33.45%	22.47%	-23.88%	3.81%	-10.6%	-11.93%	-24.47%	-36.26%	-40.6%	-85.93%	-63.11%	-85.65%
Income Tax	12.41M	11.8M	12.22M	11.09M	5.88M	6.55M	-77.18M	840K	3.79M	595K	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	24.71%	20.65%	19.83%	23.33%	14.66%	19.57%	-222.35%	2.29%	10.57%	3.23%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	37.82M	45.33M	49.38M	36.43M	34.22M	26.9M	111.9M	35.91M	32.06M	17.81M	-17.64M	2.56M	-6.37M	-6.79M	-12.23M	-14.9M	-13.76M	-25.01M	-16.65M	-17.71M
Net Margin %	30.4%	39.59%	35.48%	27.14%	28.05%	23.44%	95.19%	29.96%	29.91%	21.75%	-23.88%	3.81%	-10.6%	-11.93%	-24.47%	-36.26%	-40.6%	-85.93%	-63.11%	-85.65%
Net Income Growth %	10.53%	68.48%	-55.87%	1.45%	6.73%	51.1%	734.17%	1299.96%	603.25%	362.28%	-44.25%	117.22%	53.72%	72.85%	26.53%	15.88%	27.19%	-36.06%	14.21%	-4.7%
Net Income (Continuing)	37.82M	45.33M	49.38M	36.43M	34.22M	26.9M	111.9M	35.91M	32.06M	17.81M	-17.64M	2.56M	-6.37M	-6.79M	-12.23M	-14.9M	-13.76M	-25.01M	-16.65M	-17.71M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.16	0.19	0.20	0.15	0.14	0.11	0.46	0.15	0.13	0.08	-0.08	0.01	-0.03	-0.06	-0.06	-0.10	-0.07	-0.18	-0.09	-0.13
EPS Growth %	14.29%	72.73%	-56.52%	0%	7.69%	46.08%	688.99%	1263.64%	554.55%	230.96%	-29.52%	111%	59.2%	68.06%	34.53%	23.08%	53.27%	-12.5%	53.95%	31.58%
EPS (Basic)	0.17	0.19	0.21	0.15	0.14	0.11	0.47	0.15	0.14	0.08	-0.08	0.01	-0.03	-0.06	-0.06	-0.10	-0.07	-0.18	-0.09	-0.13
Diluted Shares Outstanding	230.34M	239.96M	243.85M	244.66M	248.61M	244.68M	245.9M	244.8M	242.17M	236.41M	225.97M	233.76M	222.68M	221.92M	202.83M	196.38M	196.35M	195.87M	180.81M	133.77M
Basic Shares Outstanding	228.23M	236.07M	237.97M	238.6M	241.49M	237.78M	236.43M	234.57M	232.42M	228.87M	225.97M	225.28M	222.68M	221.92M	202.83M	196.38M	196.35M	195.87M	180.81M	133.77M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-